Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. - Wikidata - wikimedia - TriplyDB

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells.

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells.

http://www.wikidata.org/entity/Q33992696

about

Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells Graft versus host disease: New insights into A2A receptor agonist therapy Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.Tolerogenic therapies in transplantation.T cell immune reconstitution following lymphodepletion.Regulatory T cells in graft-versus-host disease.In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice.Regulatory T-cell physiology and application to treat autoimmunity.CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance.Management of acute graft-versus-host disease.Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.Prevention and treatment of acute GvHD.Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy.Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells.Treatment of graft-versus-host disease with naturally occurring T regulatory cells.Induction of antigen-specific immune tolerance by TGF-beta-induced CD4+Foxp3+ regulatory T cells.IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation.IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantation.Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.CD4+CD25+ regulatory T-cell therapy.Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation.Natural and expanded CD4(+)CD25(+) regulatory T cells in bone marrow transplantation Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?Regulatory T-cell immunotherapy for allogeneic hematopoietic stem-cell transplantation.Optimizing the use of regulatory T cells in allotransplantation: recent advances and future perspectives.Regulatory T cells: tolerance induction in solid organ transplantation.Hurdles in therapy with regulatory T cells.Cell-Based Therapies with T Regulatory Cells.Treg therapy in transplantation: a general overview.How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model.Immunological properties of embryonic and adult stem cells.Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice.Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.TNFR2: The new Treg switch?Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells.

P2860

Q27438176-C8FAF457-46FF-4DA4-B599-56E6FC9F69AF Q28080809-26A75416-7850-4BBE-A668-4440D13A9BE8 Q33615249-AA027D48-E0A8-4010-897B-E17B1B08E7FF Q34046489-8D8023B1-39CE-434D-B3FC-24A90235B196 Q34520569-D5499643-AF23-47E6-8BDB-895D732E47CD Q34975035-BA8F60B4-23F5-4777-9AC6-69E6EBAAEA43 Q36102133-3F7E1CE4-294F-4214-B45D-96E19D41CBD9 Q36334023-4D6ACF08-4892-4DF9-A73A-7CF8BECE98B7 Q36534833-B906F4A2-07CC-4424-B947-562B24FA6AB8 Q36537036-1AD53AA0-6D23-4073-894B-3619C6874637 Q36563537-87BDAACC-040E-4B8A-9A0E-0B13231CD76E Q36600237-C9E69A3F-CCA9-4E37-9BA1-BD724E46A908 Q36773002-EF5198D1-1B2C-43FB-A00C-14FD5808715E Q37008223-852E9E8C-7D86-4029-A4EC-0770D8A88A94 Q37188487-FE7C5BBC-6666-49FE-966D-1D052D37B121 Q37294572-CEA28AF6-D722-4206-A35D-3EA1E419E4BA Q37317866-79DCEEB4-8353-4DC3-B0F4-A04C82D2E6B6 Q37321716-C599FC0C-2996-4992-AF55-45D27187CCF9 Q37405038-4FD22E11-E769-4387-8F6B-2AA605EDD712 Q37484523-807AA139-816F-4E12-A8A6-AA816B20CEA8 Q37603359-076A0FBF-CEDC-4637-A3C3-55C2C69B4DA7 Q37603497-8E204DBE-37BF-4280-B578-D4869C4353FC Q37754524-6BF96948-501B-43A5-8F8B-5525F59900F9 Q37773272-E4AC9D62-403E-483E-94C4-53D7989DF50D Q37824995-D4996B4F-3A1F-4575-B82F-74696DF44772 Q38059338-00C4313F-E126-4097-ABAB-CA53D4105E60 Q38095964-F736948A-269F-455D-A07D-96BB7CC42A50 Q38161566-7E484EE9-11F7-4AC0-A3B8-2E54698859C9 Q38557841-8D152BC1-72BE-469B-B14A-D28460952FBE Q38583881-3E170479-FBBE-41E4-99B8-3D63A7D5A7F8 Q38766028-80D69C00-4B5B-4829-91EF-652FD2555E58 Q38778543-24501501-F47A-411D-AEFA-9E6B39CB93A7 Q38852283-4F2C2059-4381-4E18-AC20-83715E689272 Q39665949-15162BF8-038D-435E-A23B-56BCB4B8A66C Q40187567-EA436BB8-F50A-4113-96DB-BC99D8F51E0E Q41998193-5620152F-4F97-4AFA-80F5-2F780AD15DA9 Q42109680-8A0316EF-DAB3-4497-80D0-CAF5E5DE933B Q46059376-F06209FC-D659-4AED-AADF-245C104D06A0 Q47381937-C3968994-D67B-455B-90AD-09DF056208ED Q47618676-8BEDD541-973F-430D-B49A-D7F7AEB39454

P2860

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells.

http://www.wikidata.org/entity/Q33992696

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Ex vivo-expanded CD4+CD25+ imm ...... tiation of pathogenic T cells.

@ast

Ex vivo-expanded CD4+CD25+ imm ...... tiation of pathogenic T cells.

@en

type

label

Ex vivo-expanded CD4+CD25+ imm ...... tiation of pathogenic T cells.

@ast

Ex vivo-expanded CD4+CD25+ imm ...... tiation of pathogenic T cells.

@en

prefLabel

Ex vivo-expanded CD4+CD25+ imm ...... tiation of pathogenic T cells.

@ast

Ex vivo-expanded CD4+CD25+ imm ...... tiation of pathogenic T cells.

@en

P1433

Q33992696-C0FA9282-5C81-41B2-B94B-CD1F612A7929

P1476

Q33992696-1A5AE36C-8377-401F-AA0E-35579BE2A659

P2093

Q33992696-11058A4E-A6BF-4F8C-9BC9-2BF0AE27B7C7

Q33992696-19F74A9F-F478-4EAD-8280-07E8E34CACB8

Q33992696-249B2490-7221-4133-9EA7-C2C615E03ECE

Q33992696-4AB13B3F-29F4-4F06-B4C1-4C59282702B2

Q33992696-84121BC3-4059-4DE2-818E-FA1F3B7CD925

Q33992696-89A68697-A7EC-4121-ACD2-6E60D4F0F7CC

Q33992696-8ED66AAA-4205-476B-8F22-6A138C4DD1BC

Q33992696-A12EAE9E-2B66-44D5-B037-E0919E4ABA89

Q33992696-A72C0EA1-C760-4030-81BA-7CBD2D47C1A9

Q33992696-F891DCEB-197D-47F4-AD06-5B30ABE89182

P304

Q33992696-16A5C6FA-6F86-4034-B401-E3CCF75A03AF

P31

Q33992696-E02358D4-C894-4BC0-B6A8-FC0046E046D0

P356

Q33992696-3DF594EA-FCF2-40FB-82F5-2A772E3D1C62

P407

Q33992696-EAA51CB2-5454-488E-B2BF-0DF6A6F174C7

P433

Q33992696-547C54E7-F7D3-45D5-AB77-8C348119CFD8

P478

Q33992696-86122674-C245-4BA7-95D9-5D13BFD014BB

P577

Q33992696-728F1310-3083-4828-AE70-F07900873285

P5875

Q33992696-5A00A4AC-F290-4150-97B1-07F86BD69221

P698

Q33992696-4BD3D61C-6740-441C-B578-742CA58E75C2

P356

JIMMUNOL.176.2.1266

P1433

Journal of Immunology

P1476

Ex vivo-expanded CD4+CD25+ imm ...... tiation of pathogenic T cells.

@en

P2093

Aurélie Trenado

http://www.w3.org/2001/XMLSchema#string

Benoît L Salomon

http://www.w3.org/2001/XMLSchema#string

David Klatzmann

http://www.w3.org/2001/XMLSchema#string

Frédéric Charlotte

http://www.w3.org/2001/XMLSchema#string

José L Cohen

http://www.w3.org/2001/XMLSchema#string

Mark Bonyhadi

http://www.w3.org/2001/XMLSchema#string

Muriel Sudres

http://www.w3.org/2001/XMLSchema#string

Qizhi Tang

http://www.w3.org/2001/XMLSchema#string

Sylvie Grégoire

http://www.w3.org/2001/XMLSchema#string

Sébastien Maury

http://www.w3.org/2001/XMLSchema#string

P304

1266-1273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.176.2.1266

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7377542

http://www.w3.org/2001/XMLSchema#string

P698

16394018

http://www.w3.org/2001/XMLSchema#string